TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TXMD TherapeuticsMD

Pre-Mkt 07-06 04:51:07 EDT

2.11

-0.05

-2.31%

High2.19	Low2.01	Vol13.61K
Open2.16	D1 Closing2.16	Amplitude8.38%
Mkt Cap24.42M	Tradable Cap20.03M	Total Shares11.57M
T/O28.68K	T/O Rate0.14%	Tradable Shares9.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TXMD","market":"US","secType":"STK","nameCN":"TherapeuticsMD","latestPrice":2.11,"timestamp":1783022400000,"preClose":2.16,"halted":0,"volume":13607,"delay":0,"changeRate":-0.02314814814814827,"floatShares":9491800,"shares":11574362,"eps":0.015465,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"07-06 04:51:07 EDT","open":2.16,"high":2.1909,"low":2.01,"amount":28683.864878899996,"amplitude":0.08375,"askPrice":2.29,"askSize":200,"bidPrice":1.74,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.015465,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783344600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1366689600000,"exchange":"NASDAQ","adjPreClose":2.11,"postHourTrading":{"tag":"盘后","latestPrice":2.11,"preClose":2.11,"latestTime":"19:48 EDT","volume":20,"amount":42.02,"timestamp":1783036132519,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.323007167819136,"impliedVol":2.9876,"impliedVolPercentile":0.96},"requestUrl":"/m/hq/s/TXMD/wiki","defaultTab":"wiki","newsList":[{"id":"2648671075","title":"Therapeuticsmd Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2648671075","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648671075?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:30","pubTimestamp":1782855000,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","IE00BN8TJ469.HKD","LU1244550494.USD","LU2237443382.USD","LU0868494708.USD","LU0310800379.SGD","BK4588","ABBV","LU2357627491.SGD","LU0198837287.USD","LU0310799852.SGD","LU1732799900.SGD","TXMD","LU0069063385.USD","IE00BVYPNV92.GBP","BK4007","LU0234572021.USD","LU0057025933.USD","LU1670627923.USD","IE0009355771.USD","LU0472753341.HKD","LU2087621335.USD","IE00B4R5TH58.HKD","LU0553294199.USD","LU1291159041.SGD","LU1551013425.SGD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","LU0114720955.EUR","BK4139","LU1023059063.AUD","LU1074936037.SGD","LU1093756168.USD","LU0820561909.HKD","LU2129689514.USD","LU1989772840.SGD","LU1162221912.USD","LU0122379950.USD","IE00B3PB1722.GBP","LU2133065610.SGD","IE00BLSP4452.SGD","LU0203345920.USD","LU0211328371.USD","IE00B2B36J28.USD","IE000F7OJYX1.SGD","SG9999015978.USD","LU1934455194.USD","LU0661504455.SGD","LU0942090050.USD","IE00B42XCP33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647302523","title":"Therapeuticsmd Inc. Stock Advances 6.2%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2647302523","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647302523?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:34","pubTimestamp":1782765240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. advanced 6.2% to $2.24 on what proved to be an all-around positive trading ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289961442.SGD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU0689626769.HKD","IE00BVYPNW00.USD","LU0738911758.USD","LU1093756168.USD","IE00B19Z3B42.SGD","LU0868494708.USD","LU0158827948.USD","LU0823416689.USD","BK4585","LU2089984988.USD","LU0545039389.USD","LU0310800379.SGD","LU2089283258.USD","SG9999001440.SGD","IE000BZT7R73.USD","IE0004445239.USD","IE0009355771.USD","LU0170899867.USD","LU0234572021.USD","LU0985320562.USD","LU1037948897.HKD","LU2237443978.SGD","LU0320765646.SGD","LU1839511570.USD","LU1934455863.HKD","TXMD","LU0795875169.SGD","LU2129689605.HKD","LU1061106388.HKD","LU1551013342.USD","IE000WAW04H5.SGD","LU1244550221.USD","LU1037948541.HKD","BK4588","ABBV","LU1718418525.SGD","BK4007","LU1023059063.AUD","LU2237443622.USD","IE0002141913.USD","IE000F7OJYX1.SGD","IE00BJJMRZ35.SGD","LU0029864427.USD","BK4581","IE00BLSP4239.USD","LU0965509283.SGD","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646393800","title":"Therapeuticsmd Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2646393800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646393800?lang=en_us&edition=fundamental","pubTime":"2026-06-27 05:29","pubTimestamp":1782509340,"startTime":"0","endTime":"0","summary":"DJ TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Share","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0511384066.AUD","LU0868494708.USD","LU0289961442.SGD","IE0002270589.USD","LU2089984988.USD","LU2129689514.USD","LU1934455277.USD","LU1267930490.SGD","LU0256863811.USD","TXMD","BK4581","LU0289739699.SGD","LU1989771016.USD","LU0211327993.USD","BK4534","BK4550","LU2089283258.USD","IE0004445239.USD","IE00BBT3K403.USD","LU2237443978.SGD","LU0057025933.USD","LU1732800096.USD","LU0029864427.USD","LU2237443895.HKD","LU0689626769.HKD","LU0823416689.USD","BK4559","LU1061106388.HKD","IE00BLSP4452.SGD","LU1839511570.USD","LU2237443465.HKD","LU0124676726.USD","LU0472753341.HKD","BK4007","IE00B19Z3581.USD","LU2237443549.SGD","LU1670628061.USD","SG9999015945.SGD","IE00BVYPNW00.USD","ABBV","BK4139","LU1003077747.HKD","LU0942090050.USD","LU0098860793.USD","LU0708994859.HKD","SG9999011175.SGD","IE00BGHQF631.EUR","LU1983299246.USD","BK4585","LU2129689605.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645084560","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2645084560","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645084560?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:31","pubTimestamp":1782163860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 2.56% to $2.00 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.29% to 51,712.71 and the NASDAQ Composite Index  falling 1.32% to 26,166.60.The stock's rise snapped a two-day losing streak.TherapeuticsMD Inc. closed 32.20% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 6.25% to $230.01.Trading volume  eclipsed its 50-day average volume of 39,628.Data source: Dow Jones Market Data, FactSet. Data compiled June 22, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644039857","title":"TherapeuticsMD Inc. Stock Slides 14.1%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2644039857","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644039857?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:32","pubTimestamp":1781814720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. plunged 14.1% to $1.95 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.9% to 26,517.93 and the Dow Jones Industrial Average rising 0.1% to 51,564.70.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 33.9% below its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its peers, as AbbVie Inc. fell 2.1% to $216.49.Trading volume totaled 69,581, compared to the 50-day average of 38,683.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643611789","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2643611789","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643611789?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:30","pubTimestamp":1781559000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 3.64% to $2.28 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 3.07% to 26,683.94 and the Dow Jones Industrial Average  rising 0.92% to 51,671.03.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed 22.71% below its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  fell 2.70% to $221.59.Trading volume  eclipsed its 50-day average volume of 36,847.Data source: Dow Jones Market Data, FactSet. Data compiled June 15, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642232446","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642232446","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642232446?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:32","pubTimestamp":1781213520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 2.15% to $1.82 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 2.54% to 25,809.66 and the Dow Jones Industrial Average  rising 1.86% to 50,848.75.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 38.31% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  fell 0.08% to $224.77.Trading volume  eclipsed its 50-day average volume of 31,408.Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642479400","title":"TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642479400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642479400?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:30","pubTimestamp":1781127000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 1.06% to $1.86 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.98% to 25,169.50 and Dow Jones Industrial Average  falling 1.87% to 49,918.78.TherapeuticsMD Inc. closed 36.95% short of its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc.  fell 0.21% to $224.95.Trading volume  eclipsed its 50-day average volume of 31,433.Data source: Dow Jones Market Data, FactSet. Data compiled June 10, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431069","title":"TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431069","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431069?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:34","pubTimestamp":1780950840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. slid 5.5% to $1.88 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.9% to 25,929.66 and the Dow Jones Industrial Average falling 0.2% to 50,786.01.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 36.3% short of its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its peers, as AbbVie Inc. fell 1.8% to $223.07.Trading volume totaled 173,719, compared to the 50-day average of 26,718.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641584160","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2641584160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641584160?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:31","pubTimestamp":1780608660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 1.52% to $2.00 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 1.73% to 51,561.93 and the NASDAQ Composite Index  falling 0.09% to 26,830.96.The stock's rise snapped a three-day losing streak.TherapeuticsMD Inc. closed 32.20% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  rose 3.60% to $224.94.Trading volume  remained 12,551 below its 50-day average volume of 24,320.Data source: Dow Jones Market Data, FactSet. Data compiled June 4, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640260669","title":"TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640260669","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640260669?lang=en_us&edition=fundamental","pubTime":"2026-06-03 05:31","pubTimestamp":1780435860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 3.77% to $2.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.03% to 27,093.90 and the Dow Jones Industrial Average  rising 0.45% to 51,307.79.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 30.85% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  rose 1.16% to $215.40.Trading volume  eclipsed its 50-day average volume of 21,118.Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639706066","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2639706066","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639706066?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:30","pubTimestamp":1780090200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 1.42% to $2.14 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.20% to 26,972.62 and the Dow Jones Industrial Average  rising 0.72% to 51,032.46.TherapeuticsMD Inc. closed 27.46% below its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its competitors Friday, as AbbVie Inc.  fell 0.42% to $217.72.Trading volume  remained 6,875 below its 50-day average volume of 21,446.Data source: Dow Jones Market Data, FactSet. Data compiled May 29, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357252","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357252?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:33","pubTimestamp":1779399180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 1.44% to $2.11 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.09% to 26,293.10 and the Dow Jones Industrial Average  rising 0.55% to 50,285.66.This was the stock's fifth consecutive day of gains.TherapeuticsMD Inc. closed 28.47% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Thursday, as AbbVie Inc.  rose 1.04% to $214.50.Trading volume  remained 8,571 below its 50-day average volume of 21,467.Data source: Dow Jones Market Data, FactSet. Data compiled May 21, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637769618","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2637769618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637769618?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:29","pubTimestamp":1779312540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 1.96% to $2.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.54% to 26,270.36 and the Dow Jones Industrial Average  rising 1.31% to 50,009.35.This was the stock's fourth consecutive day of gains.TherapeuticsMD Inc. closed 29.49% short of its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  fell 0.68% to $212.30.Trading volume  remained 11,924 below its 50-day average volume of 21,992.Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636700109","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2636700109","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636700109?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:30","pubTimestamp":1779139800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 1.00% higher to $2.02 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.32% to 49,686.12 and the NASDAQ Composite Index  falling 0.51% to 26,090.73.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed 31.53% short of its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  fell 0.47% to $209.41.Trading volume  remained 10,167 below its 50-day average volume of 22,196.Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635759140","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2635759140","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635759140?lang=en_us&edition=fundamental","pubTime":"2026-05-14 05:30","pubTimestamp":1778707800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 3.59% to $2.02 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 1.20% to 26,402.34 and the Dow Jones Industrial Average  falling 0.14% to 49,693.20.The stock's rise snapped a five-day losing streak.TherapeuticsMD Inc. closed 31.53% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  rose 0.31% to $208.50.Trading volume  eclipsed its 50-day average volume of 23,315.Data source: Dow Jones Market Data, FactSet. Data compiled May 13, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223484","title":"TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223484","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223484?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:19","pubTimestamp":1778620777,"startTime":"0","endTime":"0","summary":"TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 116.67 percent increase over losses of $(0.06) per share from the same period last year.  The company reported $724.000 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52509564/therapeuticsmd-q1-eps-0-01-up-from-0-06-yoy-sales-724-000k-up-from-393-000k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722340","title":"TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722340","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635722340?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:18","pubTimestamp":1778620735,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $724K vs. $393K y/y. The Company continues to evaluate a variety of strategic alternatives that may include, but are not limited...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/therapeuticsmd-reports-q1-eps-1c-vs-6c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/therapeuticsmd-reports-q1-eps-1c-vs-6c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635287432","title":"TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2635287432","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635287432?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:47","pubTimestamp":1778618822,"startTime":"0","endTime":"0","summary":"TherapeuticsMD ( ($TXMD) ) has provided an update. TherapeuticsMD, Inc. reported on May 12, 2026, that it generated $103,000 in net income from con...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-quarterly-profit-evaluates-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-quarterly-profit-evaluates-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247910","title":"TherapeuticsMD swings to FY26 Q1 profit of $103,000; revenue rises 84.2% to $724,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247910","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247910?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:08","pubTimestamp":1778616485,"startTime":"0","endTime":"0","summary":"TherapeuticsMD posted net income from continuing operations of $103,000 for first-quarter 2026, swinging from a loss a year earlier.License revenue rose 84.22% year over year to $724,000, driven primarily by the Mayne License Agreement.Total operating expenses fell 13.6% to $1.45 million, reflecting absence of a 2025 write-off and lower professional fees and share-based compensation.Cash and cash equivalents totaled $8.4 million at March 31, 2026.Company continued evaluating strategic alternatives, including potential acquisition, merger, business combination, or asset sale.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL33PTxg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TXMD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.lenz-tx.com","stockEarnings":[{"period":"1week","weight":0.0394},{"period":"1month","weight":0.0343},{"period":"3month","weight":0.055},{"period":"6month","weight":0.2788},{"period":"1year","weight":0.8509},{"period":"ytd","weight":0.2945}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.069114},{"month":2,"riseRate":0.461538,"avgChangeRate":-0.035452},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.013291},{"month":4,"riseRate":0.461538,"avgChangeRate":-0.016451},{"month":5,"riseRate":0.571429,"avgChangeRate":0.00831},{"month":6,"riseRate":0.571429,"avgChangeRate":0.003424},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.043424},{"month":8,"riseRate":0.461538,"avgChangeRate":0.045617},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.025286},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.071876},{"month":11,"riseRate":0.615385,"avgChangeRate":0.054051},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.035764}],"exchange":"NASDAQ","name":"TherapeuticsMD","nameEN":"TherapeuticsMD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TherapeuticsMD,TXMD,TherapeuticsMD股票,TherapeuticsMD股票老虎,TherapeuticsMD股票老虎国际,TherapeuticsMD行情,TherapeuticsMD股票行情,TherapeuticsMD股价,TherapeuticsMD股市,TherapeuticsMD股票价格,TherapeuticsMD股票交易,TherapeuticsMD股票购买,TherapeuticsMD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}